Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03735589
Title Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

fallopian tube carcinoma

ovary epithelial cancer

peritoneal carcinoma

Therapies

alphaDC1 + NK-like CTLs

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.